EXECUTIVE SEVERANCE BENEFITS AGREEMENTExecutive Severance Benefits Agreement • March 17th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
This EXECUTIVE SEVERANCE BENEFITS AGREEMENT (the “Agreement”) is entered into this fourth day of August, 2005 (the “Effective Date”), between ROBERT MCDOWELL, PH.D. (“Executive”) and SUNESIS PHARMACEUTICALS, INC. (the “Company”). This Agreement is intended to provide Executive with the compensation and benefits described herein upon the occurrence of specific events. Certain capitalized terms used in this Agreement are defined in Article 6.
COMMERCIAL SUBLEASE AGREEMENTOffice Lease • March 17th, 2008 • Sunesis Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS FIRST ADDENDUM TO OFFICE LEASE (the “First Addendum”) is made and entered into as of December 15, 2004, by and between KASHIWA FUDOSAN AMERICA, INC., a California corporation (“Landlord”) and ONCOLOGY THERAPEUTICS NETWORK JOINT VENTURE, L.P., a Delaware limited partnership (“Tenant”).
